- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Recreational / Social drugs: Cocaine
Motherisk Research
-
Reprod Toxicol 15 (4): 341-69, 2001.
Addis A, Moretti M, Syed FA, Einarson TR, Koren G. Fetal effects of cocaine: an updated meta-analysis -
The Toronto Adoption Study. Clin Invest Med 2001 Jun;24(3):129-37
Nulman I, Rovet J, Greenbaum R, Loebstein M, Wolpin J, Pace-Asciak P, Koren G. Neurodevelopment of adopted children exposed in utero to cocaine -
Neurotoxicology & Teratology. 19(1):47-57, 1997 Jan-Feb.
Morris P, Binienda Z, Gillam MP, Klein J, McMartin K, Koren G, Duhart HM, Slikker W Jr, Paule MG: The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. -
Lancet 2: 1440-1442, 1989.
Koren G, Graham K, Shear H, Einarson T: Bias against the null hypothesis; The reproductive hazards of cocaine. -
Can Med Assoc J 151: 1591-1597, 1994.
Nulman I, Rovet J, Altman D, Bradley C, Einarson T, Koren G: Neurodevelopment of adopted children exposed in utero to cocaine -
Eliopoulos C, Klein J, Koren G: Neonatal markers for intrauterine exposure to cocaine and nicotine. Can J Obstet Gynecol 6: 615-620, 1994.
-
Life Sci 50: 1333-1341, 1992.
Forman R, Graham K, Klein J, Greenwald M, Koren G: Accumulation of cocaine in fetal hair; The dose response curve. -
Reprod Toxicol 7: 619-622, 1993.
Forman R, Klein J, Meta D, Barks J, Greenwald M, Koren G: Maternal and neonatal characteristics following exposure to cocaine in Toronto. -
Clin Invest Med 17: 206-211, 1994.
Forman R, Klein J, Meta D, Barks J, Greenwald M, Koren G: Prevalence of fetal exposure to cocaine in Toronto 1990-1991. -
Vet Hum Toxicol 31: 143-148, 1988.
Graham K, Demitrakoudis D, Pellegrini E, Koren G: Pregnancy outcome following first trimester exposure to cocaine in non addict social users in Toronto. -
Potential misclassification of a case of SIDS: Maternal and neonatal hair analysis for cocaine and heroin
Graham K, Klein J, Forman R, Flynnk, Sakuma T, Davidson W, Koren G: Potential misclassification of a case of SIDS: Maternal and neonatal hair analysis for cocaine and heroin. Maternal Fetal Med 2: 91-93, 1993. Abstract.
-
JAMA 262: 3328-3330, 1989.
Graham K, Koren g, Klein J, Schneiderman J: Determination of gestational cocaine exposure by hair analysis. -
Can Med Assoc J 144: 563-568, 1991.
Graham K, Koren G: Characteristics of pregnant women exposed to cocaine in Toronto between 1985 and 1990 -
J Pediatr 115: 333, 1989. No abstract available.
Graham K, Koren G: Maternal cocaine use and risk of sudden infant death -
Johnson D, Schwartz H, Forman R, Klein J, Jacobson, S, Greenwald M, Koren G: Assessment of in utero exposure to cocaine; Radioimmunoassay testing for benzoylecgonine in meconium, neonatal hair and maternal hair. Can J Clin Pharmacol 1: 83-86, 1994.
-
Ther Drug Monit 16: 67-70, 1994.
Klein J, Forman R, Eliopoulos C, Koren G: A method of simultaneous measurement of cocaine and nicotine in neonatal hair. -
Ped Pathol, 12: 463-468, 1992.
Klein J, Greenwald M, Becker L, Koren G: Fetal distribution of cocaine: Case analysis -
Dev Pharmacol Ther 18: 228-236, 1992.
Koren G, Klein J, Forman R, Graham K, My-Khan P: Biological markers of intrauterine exposure to cocaine and cigarette smoking. -
J Clin Pharmacol 32: 671-675, 1992.
Koren G, Klein J, Forman R, Graham K: Hair Analysis of cocaine: Differentiation between systemic exposure and external contamination. -
Koren G, Klein J, Graham K, Forman R: Hair test to verify gestational cocaine exposure. In: Recent Developments in TDM and Clin Toxicology Marcel Dekker, NY 569-574, 1992.
-
Koren G: Cocaine use by pregnant women in Toronto; An alarming note. IM Paint 11: 20-21, 1995 (Winter).
-
Neurotoxicol & Teratol, 15: 301-304, 1993. No abstract available.
Koren G: Cocaine and the human fetus: The concept of teratophilia -
Emerg Med N Amer 8: 633-652, 1990.
Levy M, Koren G: Obstetric and neonatal effects of drugs of abuse. -
Teratology 44: 405-414, 1991.
Lutiger B, Graham K, Einarson T, Koren G: Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis -
Can Med Assoc J 151: 1591-1597, 1994.
Nulman I, Rovet J, Altman D, Bradley C, Einarson T, Koren G: Neurodevelopment of adopted children exposed in utero to cocaine. -
Teratology 46: 567-571, 1992.
Koren G, Gladstone D, Robeson C, Robieux I: The perception of teratogenic risk of cocaine. -
J Pediatr 125: 652-654, 1994.
Potter S, Klein J, Valiante G, Stack DM, Papageorgiou A, Stott W, Lewis D, Koren G, Zelazo PR: Maternal cocaine use without evidence of fetal exposure -
Biology of the Neonate 1997;72(6):345-351
Ursitti F, Klein J, Koren G: Clinical utilization of the neonatal hair test for cocaine: a four-year experience in Toronto. -
Life Sci. 58(5):PL 63-6, 1996.
Simone C, Byrne BM, Derewlany LO, Koren G: Cocaine inhibits hCG secretion by the human term placental cotyledon in vitro. -
Life Sci 57: 137-140, 1995. No abstract available.
Simone C, Derewlany LO, Koren G: Cocaine transfer across a cocaine-exposed placental cotyledon perfused in vitro. -
Nulman I, Koren G: Developmental outcomes of cocaine exposed infants who are adopted. Imprint 14: (Winter) 15-16, 1996.
-
Placenta. 1999 Sep;20(7):499-512. Review.
Pastrakuljic A, Derewlany LO, Koren G: Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. -
Ther Drug Monit. 1998 Oct;20(5):478-80.
Koren G, Klein J, McMartin K: Diagnosing intrauterine exposure to cocaine by hair testing: six years of clinical use. -
Ann N Y Acad Sci. 1998 Jun 21;846:306-13.
Koren G, Nulman I, Rovet J, Greenbaum R, Loebstein M, Einarson T: Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto Adoption Study -
Ursitti F, Klein J, Koren G: Confirmation of cocaine use during prengancy: a critical review. Ther Drug Monit 2001; 23: 347-53.
-
Young women taking isotretinoin still conceive: Role of physicians in preventing disaster
Gordana Atanackovic, MD; Gideon Koren, MD, FRCPC -
Children of Neverland
Gideon Koren, MD, FRCPC












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)